Comprehensive prognostic model for immunotherapy in small cell lung cancer: a multi-center study integrating clinical and blood biomarkers
{{output}}
Background: Small cell lung cancer (SCLC) is a highly aggressive and rapidly progressing form of lung cancer that is difficult to treat. Immunotherapy has provided encouraging outcomes, but only a small proportion of patients exp... ...
